Improving Knowledge in Heart Failure Inpatient With Therapeutic Education
Key facts
- Who runs it
- University Hospital, Geneva
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 38 people enrolled
- Started
- 13 Dec 2022
- Ended
- 31 Jan 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Patient therapeutic education
- Record updated
- 26 March 2024
- Why it stopped
- Difficulty in recruiting and lack of resources
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Hospitalization in the Department of General Internal Medicine or Cardiology for decompensated heart failure with lowered left ventricular ejection fraction (LVEF) (≤40%) from any cause or mildly lowered LVEF (41-49%) with the presence of heart failure-specific drug therapy
- Stability of the patient's clinical condition
- ≥ 2 heart failure medications
- ≥18 years
- Full capacity of discernment
- Absence of cognitive impairment
- Ability to speak, understand and read in French
- Get a personal telephone
- Consent form signed by the participant
Who cannot take part
- Inability to follow study procedures
- Institutionalized persons
- Asylum seekers, homeless people, prisoners
- Incapacity of judgment and discernment
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objective is to evaluate the impact of a pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients. The knowledge score on heart failure disease and medications will be compared between two groups one month after hospitalization. The intervention group will receive a therapeutic education intervention and usual hospital care and the control group will receive only usual hospital care.
The 2 groups in the trial
- "Patient therapeutic education" groupTreatment being tested
The intervention group will benefit from a pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients and usual hospital care (medical and nursing care)
Treatment: Patient therapeutic education
- "Usual hospital care" groupNo study treatment, for comparison
The control group do only benefit from the usual hospital care (any medical and nursing care giving to an acute heart failure inpatient) and won't benefit from the pharmacist's educational intervention.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Disease and Medication Knowledge Improvement: A Swiss Single-center Randomized Controlled Trial With Heart Failure Inpatients
- Record updated
- 26 March 2024